Measurement of soluble pyrophosphate in plasma and synovial fluid of patients with various rheumatic diseases.

No abstract is available for this paper.

• Publication year

  1981

• Venue

  Scandinavian Journal of Rheumatology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.3109/03009748109095305PMID 6270783
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Influence of extracellular pyrophosphate on the synthesis of collagen by chondrocytes

  1978cited by this paper
• Inorganic pyrophosphatase activity of the synovial fluid.

  1978cited by this paper
• Inorganic pyrophosphatase activity of the synovial fluid. Kinetic and clinical study.

  1978cited by this paper
• Destructive arthropathy in chondrocalcinosis articularis.

  1976cited by this paper
• Metabolism of inorganic pyrophosphate (PPi).

  1976cited by this paper
• Inorganic pyrophosphate and proteoglycan metabolism in cultured human articular chondrocytes and fibroblasts.

  1976cited by this paper
• Pseudogout: clinical observations and chemical analyses of deposits.

  1976cited by this paper
• Extrusion of pyrophosphate into extracellular media by osteoarthritic cartilage incubates.

  1975cited by this paper
• Destructive arthropathy in generalized osteoarthritis with articular chondrocalcinosis.

  1975cited by this paper
• Technetium-99m-pyrophosphate kinetics and imaging in metabolic bone disease.

  1975cited by this paper
• Destructive arthropathy in generalized osteoarthritis with articular chondrocalcinosis.

  1975cited by this paper
• Elevated inorganic pyrophosphate concentrations in synovial fluids in osteoarthritis and pseudogout.

  1974cited by this paper
• Elevated inorganic pyrophosphate concentrations in synovial fluids in osteoarthritis and pseudogout.

  1974cited by this paper
• Measurement of inorganic pyrophosphate in biological fluids and bone tissues.

  1974cited by this paper
• Measurement of inorganic pyrophosphate in biological fluids. Elevated levels in some patients with osteoarthritis, pseudogout, acromegaly, and uremia.

  1973cited by this paper
• Articular chondrocalcinosis. Microanalysis of pyrophosphate (PPi) in synovial fluid and plasma.

  1973cited by this paper
• [Study of the synovial fluid and plasma in articular chondrocalcinosis].

  1972cited by this paper
• Advantages of the use of Cerenkov vounting for determination of P 32 in photophosphorylation research.

  1972cited by this paper
• Inorganic pyrophosphate concentrations in the synovial fluid of arthritic patients.

  1971cited by this paper
• Inorganic pyrophosphate in plasma, urine, and synovial fluid of patients with pyrophosphate arthropathy (chondrocalcinosis or pseudogout).

  1970cited by this paper
• THE SPECIFIC PRECIPITATION OF ORTHOPHOSPHATE AND SOME BIOCHEMICAL APPLICATIONS.

  1964cited by this paper

• A copper ion-mediated on-off-on gold nanocluster for pyrophosphate sensing and bioimaging in cells.

  2023cites this paper
• Inorganic Pyrophosphatase–Nanodiamond Conjugates Hydrolyze Pyrophosphate in Human Synovial Fluid

  2020cites this paper
• Signal-on fluorescence assay for pyrophosphate ions based on DNA-stabilized silver nanoclusters.

  2019cites this paper
• Highly sensitive electrochemiluminescent sensing platform based on graphite carbon nitride nanosheets for detection of pyrophosphate ion in the synovial fluid

  2016cites this paper
• Update on calcium pyrophosphate deposition.

  2016cites this paper
• Measurement of pyrophosphate concentration in cells by simple terpyridine-Zn(II) probe

  2015cites this paper
• Fluorescent sensing of pyrophosphate anion in synovial fluid based on DNA-attached magnetic nanoparticles.

  2015cites this paper
• Cysteine-directed fluorescent gold nanoclusters for the sensing of pyrophosphate and alkaline phosphatase

  2014cites this paper
• Chondrocalcinose articulaire

  2002cites this paper
• Management of a patient with calcium pyrophosphate deposition disease and meniscal tear of the knee: a case report.

  1998cites this paper
• Diseases associated with calcium pyrophosphate deposition disease.

  1992cites this paper
• Synovial fluid pyrophosphate and nucleoside triphosphate pyrophosphatase: comparison between normal and diseased and between inflamed and non-inflamed joints.

  1991cites this paper
• Inorganic pyrophosphate, nucleoside triphosphate pyrophosphatase, and cartilage fragments in normal human synovial fluid.

  1991cites this paper
• Inorganic pyrophosphate in metabolic diseases predisposing to calcium pyrophosphate dihydrate crystal deposition.

  1991cites this paper
• Arthritis of the glenohumeral joint.

  1989cites this paper
• Clinical aspects of calcium pyrophosphate dihydrate crystal deposition.

  1988cites this paper
• Crystal deposition disease in the elderly.

  1986cites this paper
• Adenosine triphosphate pyrophosphohydrolase and neutral inorganic pyrophosphatase in pathologic joint fluids. Elevated pyrophosphohydrolase in calcium pyrophosphate dihydrate crystal deposition disease.

  1985cites this paper
• Partial characterization of synovial fluid nucleotide pyrophosphohydrolase.

  1985cites this paper
• Calcium pyrophosphate dihydrate crystal deposition in rheumatoid arthritis

  1985cites this paper
• Calcium pyrophosphate dihydrate crystal deposition in rheumatoid arthritis.

  1985cites this paper
• Proceedings of a symposium on crystal-related arthropathies. 22 October and 23 October, 1982, Bristol Polytechnic, Bristol.

  1983cites this paper
• Pathogenesis of chondrocalcinosis and pseudogout. Metabolism of inorganic pyrophosphate and production of calcium pyrophosphate dihydrate crystals.

  1983cites this paper